RiverPark Advisors LLC increased its holdings in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 7.8% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,800 shares of the company’s stock after purchasing an additional 2,000 shares during the quarter. RiverPark Advisors LLC’s holdings in Express Scripts were worth $1,760,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently bought and sold shares of the company. Dodge & Cox grew its position in shares of Express Scripts by 25.7% during the second quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock worth $2,310,275,000 after purchasing an additional 7,388,021 shares in the last quarter. Pzena Investment Management LLC purchased a new stake in shares of Express Scripts during the second quarter worth about $181,234,000. Baupost Group LLC MA purchased a new stake in shares of Express Scripts during the first quarter worth about $80,978,000. Northern Trust Corp grew its holdings in Express Scripts by 12.2% during the 2nd quarter. Northern Trust Corp now owns 11,068,777 shares of the company’s stock valued at $706,629,000 after buying an additional 1,206,980 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its stake in shares of Express Scripts by 23.5% in the 3rd quarter. Ameriprise Financial Inc. now owns 5,233,327 shares of the company’s stock valued at $331,374,000 after purchasing an additional 996,816 shares during the last quarter. 88.44% of the stock is currently owned by institutional investors.
Express Scripts Holding Company (NASDAQ:ESRX) opened at $67.41 on Friday. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. The stock has a market cap of $38,840.00, a P/E ratio of 9.92, a PEG ratio of 1.00 and a beta of 0.88. Express Scripts Holding Company has a 1-year low of $55.80 and a 1-year high of $75.99.
Express Scripts (NASDAQ:ESRX) last released its earnings results on Tuesday, October 24th. The company reported $1.90 EPS for the quarter, meeting the consensus estimate of $1.90. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The business had revenue of $24.68 billion during the quarter, compared to analyst estimates of $25.68 billion. During the same period in the prior year, the business earned $1.74 earnings per share. The business’s quarterly revenue was down 2.9% on a year-over-year basis. analysts anticipate that Express Scripts Holding Company will post 7.01 EPS for the current fiscal year.
In other news, VP Phyllis S. Anderson sold 643 shares of the stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total transaction of $40,103.91. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Woodrow A. Myers, Jr. sold 3,900 shares of the stock in a transaction on Monday, September 11th. The stock was sold at an average price of $63.93, for a total transaction of $249,327.00. Following the transaction, the director now owns 11,500 shares in the company, valued at approximately $735,195. The disclosure for this sale can be found here. 0.68% of the stock is currently owned by corporate insiders.
ESRX has been the subject of a number of research analyst reports. ValuEngine lowered Express Scripts from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Robert W. Baird restated a “hold” rating and set a $56.00 target price on shares of Express Scripts in a research note on Friday, September 1st. Jefferies Group set a $72.00 price objective on Express Scripts and gave the stock a “buy” rating in a research note on Tuesday, August 29th. Raymond James Financial restated an “underperform” rating on shares of Express Scripts in a research report on Monday, October 9th. Finally, Zacks Investment Research cut Express Scripts from a “buy” rating to a “sell” rating in a research note on Tuesday, October 24th. Six investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $70.67.
ILLEGAL ACTIVITY NOTICE: “Express Scripts Holding Company (ESRX) Shares Bought by RiverPark Advisors LLC” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://ledgergazette.com/2017/12/08/express-scripts-holding-company-esrx-shares-bought-by-riverpark-advisors-llc.html.
Express Scripts Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.